Healthcare Innovation Fund IV Offshore SICAV-RAIF S.C.Sp. — Form D/A
Healthcare Innovation Fund IV Offshore SICAV-RAIF S.C.Sp. of LUXEMBOURG, N4, a pooled investment fund, filed a Form D amendment with the SEC on 2022-11-03. $84.1M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-11-03
- Form: D/A
- Accession: 0001012975-22-000478
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $84.1M
- Minimum investment: $250K
- Investors: 86
- Date of first sale: 2022-07-27
- Security types: fund interests
- SEC file number: 021-455174
Issuer
- Name: Healthcare Innovation Fund IV Offshore SICAV-RAIF S.C.Sp.
- CIK: 0001936436
- Entity type: Other
- Jurisdiction: LUXEMBOURG
- Incorporated: 2022
- Address: 2, RUE JEAN MONNET, LUXEMBOURG, N4, L-2180
- Phone: 352 44 66 44 5222
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| N/A J.P. Morgan Private Investments Inc. | Executive Officer | New York, NY |
| N/A J.P. Morgan Private Investments Inc. | Promoter | New York, NY |
| Darren Gorman | Director | Luxembourg, N4 |
| Martin Vogel | Director | Luxembourg, N4 |
| N/A Waystone Management Company (Lux) S.A. | Executive Officer | Luxembourg, N4 |
| Catherine Crowley | Director | New York, NY |
| N/A Healthcare Innovation IV GP S.a r.l. | Executive Officer | Luxembourg, N4 |
| N/A Waystone Management Company (Lux) S.A | Executive Officer | Luxembourg, N4 |
| Caoimhghin O'Donnell | Director | Luxembourg, N4 |
Other filings by this issuer (4)
More